Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis
- 3 April 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 155, 158141
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Yunnan Province (202401AV070003)
- National Natural Science Foundation of China (22377105)
- National Natural Science Foundation of China (82174058)
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515010097)
This publication has 20 references indexed in Scilit:
- Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategiesPhytomedicine, 2025
- Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomicsPhytomedicine, 2023
- Nephroprotective Effects of Cardamonin on Renal Ischemia Reperfusion Injury/UUO-Induced Renal FibrosisJournal of Agricultural and Food Chemistry, 2023
- Kidney fibrosis: from mechanisms to therapeutic medicinesSignal Transduction and Targeted Therapy, 2023
- Inhibition of Ubiquitin-specific Protease 4 Attenuates Epithelial—Mesenchymal Transition of Renal Tubular Epithelial Cells via Transforming Growth Factor Beta Receptor Type ICurrent Medical Science, 2022
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2020
- Deubiquitylating enzymes and drug discovery: emerging opportunitiesNature Reviews Drug Discovery, 2017
- Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathyPhytomedicine, 2017
- TGF-β: the master regulator of fibrosisNature Reviews Nephrology, 2016
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastomaNature Medicine, 2012